Holen Sie sich die Stockscreener-App
33.68
1.26%
0.42
Handel nachbörslich:
33.60
-0.08
-0.24%
Schlusskurs vom Vortag:
$33.26
Offen:
$33.26
24-Stunden-Volumen:
322.34K
Relative Volume:
0.95
Marktkapitalisierung:
$1.37B
Einnahmen:
$1.46B
Nettoeinkommen (Verlust:
$92.09M
KGV:
14.93
EPS:
2.2555
Netto-Cashflow:
$47.29M
1W Leistung:
-0.65%
1M Leistung:
-38.94%
6M Leistung:
-22.09%
1J Leistung:
+44.92%
1-Tages-Spanne:
$32.77
$34.01
1-Wochen-Bereich:
$32.30
$34.81
52-Wochen-Spanne:
$22.85
$60.08
Phibro Animal Health Corp Stock (PAHC) Company Profile
Firmenname
Phibro Animal Health Corp
Sektor
Telefon
201-329-7300
Adresse
GLENPOINTE CENTRE EAST, 3RD FLOOR, TEANECK, NJ
Compare PAHC vs TAK, HLN, TEVA, ZTS, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PAHC
Phibro Animal Health Corp
|
33.68 | 1.35B | 1.46B | 92.09M | 47.29M | 2.2555 |
TAK
Takeda Pharmaceutical Co Adr
|
15.87 | 51.34B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.24 | 41.15B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.61 | 39.67B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
80.23 | 34.09B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
578.43 | 24.13B | 3.17B | 1.29B | 1.01B | 27.09 |
Phibro Animal Health Corp Stock (PAHC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-15 | Eingeleitet | Citigroup | Neutral |
| 2025-07-07 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2025-06-16 | Hochstufung | BNP Paribas Exane | Underperform → Neutral |
| 2024-09-10 | Eingeleitet | JP Morgan | Neutral |
| 2023-12-07 | Eingeleitet | Exane BNP Paribas | Underperform |
| 2022-12-21 | Eingeleitet | ROTH Capital | Buy |
| 2022-07-25 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2022-01-10 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2021-11-18 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Neutral |
| 2021-07-07 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2020-08-06 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2020-02-06 | Herabstufung | Gabelli & Co | Buy → Hold |
| 2020-01-28 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2019-09-05 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2019-08-29 | Bestätigt | BofA/Merrill | Underperform |
| 2019-06-11 | Eingeleitet | Barclays | Underweight |
| 2019-05-23 | Eingeleitet | Guggenheim | Neutral |
| 2019-05-09 | Hochstufung | Gabelli & Co | Hold → Buy |
| 2017-08-23 | Fortgesetzt | BofA/Merrill | Underperform |
| 2017-06-02 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2016-12-15 | Eingeleitet | Piper Jaffray | Overweight |
| 2016-11-11 | Herabstufung | Macquarie | Neutral → Underperform |
| 2016-11-10 | Herabstufung | Gabelli & Co | Buy → Hold |
| 2016-04-11 | Bestätigt | Guggenheim | Buy |
| 2016-02-04 | Eingeleitet | Credit Suisse | Outperform |
| 2016-01-15 | Herabstufung | Barclays | Overweight → Underweight |
| 2015-09-30 | Eingeleitet | Gabelli & Co | Buy |
| 2015-04-24 | Bestätigt | Barclays | Overweight |
| 2015-04-21 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2014-05-06 | Eingeleitet | Barclays | Overweight |
Alle ansehen
Phibro Animal Health Corp Aktie (PAHC) Neueste Nachrichten
Should Value Investors Buy Phibro Animal Health (PAHC) Stock? - Yahoo Finance
Phibro's CEO transition puts this insider sale in context - AOL.com
Phibro's CEO transition puts this insider sale in context - The Motley Fool
Phibro Animal Health (PAHC) major holder adopts 10b5-1 sale plan - Stock Titan
PAHCPhibro Animal Health Corp Stock Price and Quote - Finviz
PAHC Stock Price, Quote & Chart | PHIBRO ANIMAL HEALTH CORP-A (NASDAQ:PAHC) - ChartMill
Phibro leaders to address investors at Stifel 'Jaws & Paws' in New York - Stock Titan
Phibro Animal Health Corporation to Participate in Stifel Jaws & Paws Conference - Yahoo Finance
PAHC Technical Analysis & Stock Price Forecast - Intellectia AI
Phibro Animal Health Corporation (PAHC) Price Target Cut to $44 by Citi Amid Sector Pressure - Insider Monkey
Phibro Animal Health (PAHC): Buy, Sell, or Hold Post Q1 Earnings? - Yahoo Finance
Phibro (PAHC) Q1 2026 Earnings: EPS $0.76 Beats EstimatesSocial Buy Zones - Newser
Barclays PLC holds 263,695 shares in Phibro (NASDAQ: PAHC) - Stock Titan
PAHC Maintained by Citigroup -- Price Target Lowered to $44 - GuruFocus
Phibro Animal Health Corp at Bank of America Global Healthcare Conference Transcript - GuruFocus
Phibro Animal Health Sales Grow 10 Percent to 383 Million Dollars - HarianBasis.co
Earnings call transcript: Phibro Animal Health Q3 2026 sees earnings beat, stock tumbles - Investing.com
Phibro Animal Health Corporation (PAHC) Announces Financial Results for Q3 - Insider Monkey
Phibro Animal Health Corp (FRA:PB8) Stock Price & 30 Year Financial Data - GuruFocus
Phibro (PAHC) is an Incredible Growth Stock: 3 Reasons Why - Yahoo Finance
Why Phibro Animal Health (PAHC) is a Top Value Stock for the Long-Term - Yahoo Finance
Q2 2026 Phibro Animal Health Corp Earnings Call Transcript - GuruFocus
Why Phibro Animal Health (PAHC) is a Top Growth Stock for the Long-Term - Yahoo Finance
Down 30.9% in 4 Weeks, Here's Why Phibro (PAHC) Looks Ripe for a Turnaround - Yahoo Finance
Deciphering Phibro (PAHC) International Revenue Trends - Yahoo Finance
Q3 2026 Phibro Animal Health Corp Earnings Call Transcript - GuruFocus
Phibro Sustainable Solutions Platform helps protein producers target greenhouse gas emissions - The National Provisioner
Are Investors Undervaluing Phibro Animal Health (PAHC) Right Now? - Yahoo Finance
PAHC Stock Falls Despite Q3 Earnings & Revenue Beat, Margins Rise - Yahoo Finance
Phibro Animal Health CEO Jack Bendheim sells $1.02m in PAHC shares By Investing.com - Investing.com Australia
Phibro Animal Health CEO Jack Bendheim sells $1.02m in PAHC shares - Investing.com
CEO-linked BFI Co. (PAHC) sells 18,608 Phibro shares under plan - Stock Titan
Phibro executives take Bank of America health conference stage May 13 - Stock Titan
Phibro Animal Health Corporation to Participate in Bank of America Securities Health Care Conference - ChartMill
Phibro Q3 FY2026 slides: 10% sales growth amid regulatory headwinds - Investing.com
Earnings call transcript: Phibro Animal Health beats Q3 2026 expectations By Investing.com - Investing.com South Africa
Earnings call transcript: Phibro Animal Health beats Q3 2026 expectations - Investing.com
Phibro Animal Health Reports Strong Q3 2026 Results, Raises Full-Year Guidance with 14% Sales Growth - Minichart
Phibro Animal Health Corp reports results for the quarter ended March 31Earnings Summary - TradingView
MSN Money - MSN
Compared to Estimates, Phibro (PAHC) Q3 Earnings: A Look at Key Metrics - Yahoo Finance
Phibro Animal Health (PAHC) Q3 Earnings and Revenues Surpass Estimates - Yahoo Finance
Phibro: Fiscal Q3 Earnings Snapshot - KTVB
Phibro Animal Health (PAHC) posts 10% Q3 sales growth and raises 2026 guidance - Stock Titan
Phibro Animal Health’s (NASDAQ:PAHC) Q1 CY2026: Beats On Revenue - Yahoo Finance
Animal health demand pushes Phibro sales to $383.5M in Q3 - Stock Titan
Phibro Animal Health Corporation Reports Third Quarter Results, Updates Financial Guidance - marketscreener.com
Phibro Animal Health (PAHC) lifts sales and profit in Q3 2026 - Stock Titan
Phibro Animal Health earnings on deck: Can MFA momentum hold? By Investing.com - Investing.com South Africa
Phibro Animal Health earnings on deck: Can MFA momentum hold? - Investing.com
Phibro Animal Health Corporation Launches Companywide Sustainable Solutions Platform; Introduces VERRATAIN™ Verified Sustainability Solutions Through Strategic VAXA Technologies Partnership - 01net
Finanzdaten der Phibro Animal Health Corp-Aktie (PAHC)
Umsatz
Nettogewinn
Free Cashflow
ENV
Phibro Animal Health Corp-Aktie (PAHC) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| BENDHEIM JACK | President and CEO |
May 05 '26 |
Sale |
55.80 |
7,040 |
392,810 |
67,720 |
| BENDHEIM JACK | President and CEO |
May 07 '26 |
Sale |
48.49 |
4,528 |
219,568 |
56,152 |
| BENDHEIM JACK | President and CEO |
Apr 28 '26 |
Sale |
55.91 |
7,040 |
393,575 |
88,840 |
| BENDHEIM JACK | President and CEO |
Apr 29 '26 |
Sale |
52.92 |
7,040 |
372,553 |
81,800 |
| BENDHEIM JACK | President and CEO |
Apr 30 '26 |
Sale |
52.76 |
7,040 |
371,465 |
74,760 |
| BENDHEIM JACK | President and CEO |
Apr 21 '26 |
Sale |
55.98 |
7,040 |
394,081 |
109,960 |
| BENDHEIM JACK | President and CEO |
Apr 22 '26 |
Sale |
54.29 |
7,040 |
382,185 |
102,920 |
| BENDHEIM JACK | President and CEO |
Apr 23 '26 |
Sale |
54.09 |
7,040 |
380,826 |
95,880 |
| BENDHEIM JACK | President and CEO |
Apr 14 '26 |
Sale |
59.08 |
7,040 |
415,922 |
31,080 |
| BENDHEIM JACK | President and CEO |
Apr 15 '26 |
Sale |
56.96 |
7,040 |
401,011 |
24,040 |
5.02%
5.78%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):